-
1
-
-
0036119754
-
Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
-
10.1016/S0002-9343(01)01102-0, 11893380
-
Apisarnthanarak A, Khoury H, Reinus WR, Crippin JS, Mundy LM. Severe Clostridium difficile colitis: the role of intracolonic vancomycin?. Am J Med 2002, 112:329-329. 10.1016/S0002-9343(01)01102-0, 11893380.
-
(2002)
Am J Med
, vol.112
, pp. 329-329
-
-
Apisarnthanarak, A.1
Khoury, H.2
Reinus, W.R.3
Crippin, J.S.4
Mundy, L.M.5
-
2
-
-
33746333279
-
An update diagnosis, treatment, and prevention of Clostridium difficile associated disease
-
Aslam S, Musher D. An update diagnosis, treatment, and prevention of Clostridium difficile associated disease. Gastroenterol Clin Am 2006, 35:315-335.
-
(2006)
Gastroenterol Clin Am
, vol.35
, pp. 315-335
-
-
Aslam, S.1
Musher, D.2
-
3
-
-
84855422347
-
The epidemiology of community acquired Clostridium difficile infection: A population based study
-
10.1038/ajg.2011.398, 3273904, 22108454
-
Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community acquired Clostridium difficile infection: A population based study. Am J Gastroenterol 2012, 107(1):89-95. http://www.endonurse.com/, 10.1038/ajg.2011.398, 3273904, 22108454.
-
(2012)
Am J Gastroenterol
, vol.107
, Issue.1
, pp. 89-95
-
-
Khanna, S.1
Pardi, D.S.2
Aronson, S.L.3
Kammer, P.P.4
Orenstein, R.5
St Sauver, J.L.6
Harmsen, W.S.7
Zinsmeister, A.R.8
-
4
-
-
0017801430
-
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
-
10.1056/NEJM197803092981003, 625309
-
Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978, 298:531-534. 10.1056/NEJM197803092981003, 625309.
-
(1978)
N Engl J Med
, vol.298
, pp. 531-534
-
-
Bartlett, J.G.1
Chang, T.W.2
Gurwith, M.3
Gorbach, S.L.4
Onderdonk, A.B.5
-
5
-
-
39749120072
-
Antimicrobial Associated Risk Factors for Clostridium difficile Infection
-
Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial Associated Risk Factors for Clostridium difficile Infection. Clin Infect Dis 2008, 46(Suppl 1):S19.
-
(2008)
Clin Infect Dis
, vol.46
, Issue.SUPPL. 1
-
-
Owens, R.C.1
Donskey, C.J.2
Gaynes, R.P.3
Loo, V.G.4
Muto, C.A.5
-
6
-
-
77950649872
-
Hyper-virulent Clostridium difficile strains in hospitalised patients, Canada
-
10.3201/eid1604.091152, 3321949, 20350386
-
Mulvey MR, Boyd DA, Gravel D, Hutchinson J, Kelly S, Mcgeer A, Moore D, Simor A, Suh KN, Taylor G, Weese S, Miller M. Hyper-virulent Clostridium difficile strains in hospitalised patients, Canada. Emerg Infect Dis 2010, 16(4):678-681. 10.3201/eid1604.091152, 3321949, 20350386.
-
(2010)
Emerg Infect Dis
, vol.16
, Issue.4
, pp. 678-681
-
-
Mulvey, M.R.1
Boyd, D.A.2
Gravel, D.3
Hutchinson, J.4
Kelly, S.5
Mcgeer, A.6
Moore, D.7
Simor, A.8
Suh, K.N.9
Taylor, G.10
Weese, S.11
Miller, M.12
-
7
-
-
77951026738
-
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)
-
10.1086/651706, 20307191
-
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455. 10.1086/651706, 20307191.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 431-455
-
-
Cohen, S.H.1
Gerding, D.N.2
Johnson, S.3
Kelly, C.P.4
Loo, V.G.5
McDonald, L.C.6
Pepin, J.7
Wilcox, M.H.8
-
8
-
-
84856712211
-
Outcomes in community-acquired Clostridium difficile infection
-
10.1111/j.1365-2036.2011.04984.x, 3293482, 22229532
-
Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther 2012, 35(5):613-618. 10.1111/j.1365-2036.2011.04984.x, 3293482, 22229532.
-
(2012)
Aliment Pharmacol Ther
, vol.35
, Issue.5
, pp. 613-618
-
-
Khanna, S.1
Pardi, D.S.2
Aronson, S.L.3
Kammer, P.P.4
Baddour, L.M.5
-
9
-
-
33644870954
-
The outcome of surgery in fulminant Clostridium difficile colitis
-
10.1111/j.1463-1318.2005.00876.x, 16412077
-
Koss K, Clark MA, Sanders DS, Morton D, Keighley MB, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006, 8(2):149-154. 10.1111/j.1463-1318.2005.00876.x, 16412077.
-
(2006)
Colorectal Dis
, vol.8
, Issue.2
, pp. 149-154
-
-
Koss, K.1
Clark, M.A.2
Sanders, D.S.3
Morton, D.4
Keighley, M.B.5
Goh, J.6
-
10
-
-
67650766698
-
Truncation in the tcdC region of the Clostridium difficile PatLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A
-
10.1186/1471-2334-9-103, 2707377, 19558711
-
Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ. Truncation in the tcdC region of the Clostridium difficile PatLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis 2009, 9:103. 10.1186/1471-2334-9-103, 2707377, 19558711.
-
(2009)
BMC Infect Dis
, vol.9
, pp. 103
-
-
Murray, R.1
Boyd, D.2
Levett, P.N.3
Mulvey, M.R.4
Alfa, M.J.5
-
11
-
-
0035198313
-
PCR ribotyping of clinically important Clostridium difficile strains from Hungary
-
Urbán E, Brazier JS, Sóki J, Nagy E, Duerden BI. PCR ribotyping of clinically important Clostridium difficile strains from Hungary. J Med Microbiol 2001, 50:1082-1086.
-
(2001)
J Med Microbiol
, vol.50
, pp. 1082-1086
-
-
Urbán, E.1
Brazier, J.S.2
Sóki, J.3
Nagy, E.4
Duerden, B.I.5
-
12
-
-
80955180278
-
Toxicmegacolon associated Clostridium difficile colitis
-
10.4253/wjge.v2.i8.293, 2999149, 21160629
-
Sayedy L, Kothari D, Richards RJ. Toxicmegacolon associated Clostridium difficile colitis. World J Gastrointest Endosc 2010, 2(8):293-297. 10.4253/wjge.v2.i8.293, 2999149, 21160629.
-
(2010)
World J Gastrointest Endosc
, vol.2
, Issue.8
, pp. 293-297
-
-
Sayedy, L.1
Kothari, D.2
Richards, R.J.3
|